Instead, it works by supporting tissue repair, reducing inflammation, and promoting healing in areas like muscles, tendons, and ligaments
Commenters also noted that, in some cases, a finalized CAR T-cell product is never administered to the beneficiary due to factors such as manufacturing failure or disease progression that may render the patient ineligible or result in death during the production period
The clinical evidence is strong enough that these peptides are widely used in optimization medicine, but the human trial data is limited
Higher doses of etanercept do not appear to offer any benefit in PsA, at least for joint and tendon manifestations
Social interest data as a proxy for off-label performance-enhancing drug use: implications and clinical considerations